Epstein Secrets

y determination on that ground. But I don't have any reason to think that he should not remain in place.' Garland also would not commit to releasing Durham's full report. 'I am a great believer in transparency,' Garland said. 'I would, though, have to talk with Mr. Durham and understand the nature of w

on whether he would commit to allowing Durham to continue his probe through the Biden administration. `Will you commit to providing Special Counsel Durham with staff, resources and funds needed to thoroughly complete his investigation?' Grassley asked." Garland "said that, at this point, he does not h

Sees "No Reason" Why Durham Probe Should Not Be Left In Place. Fox News (2/22, Singman, 23.99M) reports that Garland "said he sees 'no reason' why" Durham "should not be left in place to continue his investigation into the origins of the Trump-Russia probe - but he wouldn't explicitly make a committal

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

on his show Wednesday night, and they touched on Attorney General William Barr's testimony the day before in which he refused to rule out releasing Durham's report before Election Day." Hannity "mentioned that Democrats are 'scared to death' of Durham's criminal inquiry into the Russia investigation,

y before in which he refused to rule out releasing Durham's report before Election Day." Hannity "mentioned that Democrats are 'scared to death' of Durham's criminal inquiry into the Russia investigation, a point which Bongino drew out in his comments." He said, "There are three things we know now tha

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

on his show Wednesday night, and they touched on Attorney General William Barr's testimony the day before in which he refused to rule out releasing Durham's report before Election Day." Hannity "mentioned that Democrats are 'scared to death' of Durham's criminal inquiry into the Russia investigation,

y before in which he refused to rule out releasing Durham's report before Election Day." Hannity "mentioned that Democrats are 'scared to death' of Durham's criminal inquiry into the Russia investigation, a point which Bongino drew out in his comments." He said, "There are three things we know now tha

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

on his show Wednesday night, and they touched on Attorney General William Barr's testimony the day before in which he refused to rule out releasing Durham's report before Election Day." Hannity "mentioned that Democrats are `scared to death' of Durham's criminal inquiry into the Russia investigation,

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

shipyard." The FBI and NCIS are investigating the case. Michigan School Board Meeting Disrupted By Bomb Threat. Adrian (MI) Daily Telegram (1/26, Durham, 26K) reports that the FBI is "investigating bomb threats made during an Addison school board meeting Monday night." The threats "were made over th

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report